137 related articles for article (PubMed ID: 16385491)
21. Poor response of anti-SRP-positive idiopathic immune myositis to B-cell depletion.
Whelan BR; Isenberg DA
Rheumatology (Oxford); 2009 May; 48(5):594-5. PubMed ID: 19254917
[No Abstract] [Full Text] [Related]
22. A review of the current use of rituximab in autoimmune diseases.
Gürcan HM; Keskin DB; Stern JN; Nitzberg MA; Shekhani H; Ahmed AR
Int Immunopharmacol; 2009 Jan; 9(1):10-25. PubMed ID: 19000786
[TBL] [Abstract][Full Text] [Related]
23. B cells in the pathophysiology of autoimmune neurological disorders: a credible therapeutic target.
Dalakas MC
Pharmacol Ther; 2006 Oct; 112(1):57-70. PubMed ID: 16644016
[TBL] [Abstract][Full Text] [Related]
24. The effects of rituximab on immunocompetency in patients with autoimmune disease.
Looney RJ; Srinivasan R; Calabrese LH
Arthritis Rheum; 2008 Jan; 58(1):5-14. PubMed ID: 18163518
[No Abstract] [Full Text] [Related]
25. Autoimmune diseases. New ways to intervene when the body attacks itself.
Kher U
Time; 2001 Jan; 157(2):76, 79. PubMed ID: 11195694
[No Abstract] [Full Text] [Related]
26. Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells.
Liossis SN; Sfikakis PP
Clin Immunol; 2008 Jun; 127(3):280-5. PubMed ID: 18337174
[TBL] [Abstract][Full Text] [Related]
27. Use of rituximab in patients with systemic lupus erythematosus: an update.
García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Galarza-Maldonado C; Sandoval-Cruz M; Zamudio-Huerta L; López-Colombo A; Cervera R
Autoimmun Rev; 2009 Feb; 8(4):343-8. PubMed ID: 19036350
[TBL] [Abstract][Full Text] [Related]
28. Success of prednisone in the treatment of a patient with sarcoidosis and systemic sclerosis: Report of a case.
Borges da Costa J; Mayer-da-Silva A; Soares de Almeida LM; Marques Gomes M
Dermatol Online J; 2009 Mar; 15(3):11. PubMed ID: 19379655
[TBL] [Abstract][Full Text] [Related]
29. Animal models of systemic sclerosis: prospects and limitations.
Beyer C; Schett G; Distler O; Distler JH
Arthritis Rheum; 2010 Oct; 62(10):2831-44. PubMed ID: 20617524
[No Abstract] [Full Text] [Related]
30. The immunologic and genetic basis of avian scleroderma, an inherited fibrotic disease of line 200 chickens.
Van de Water J; Boyd R; Wick G; Gershwin ME
Int Rev Immunol; 1994; 11(3):273-82. PubMed ID: 7930849
[No Abstract] [Full Text] [Related]
31. B cell signalling as therapeutic target.
Carter RH
Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii65-ii66. PubMed ID: 15479875
[No Abstract] [Full Text] [Related]
32. The advent of monoclonal antibodies in the treatment of chronic autoimmune diseases.
Bruno V; Battaglia G; Nicoletti F
Neurol Sci; 2011 Jan; 31 Suppl 3():283-8. PubMed ID: 20644974
[TBL] [Abstract][Full Text] [Related]
33. Mouse opens door for study of autoimmune diseases.
Check E
Nature; 2004 Apr; 428(6985):786. PubMed ID: 15103338
[No Abstract] [Full Text] [Related]
34. B cell targeted therapy in autoimmunity.
Blank M; Shoenfeld Y
J Autoimmun; 2007; 28(2-3):62-8. PubMed ID: 17391915
[TBL] [Abstract][Full Text] [Related]
35. Microchimeric cells: guardians or actors of immunity in scleroderma?
Lambert NC
Rheumatology (Oxford); 2007 Mar; 46(3):382-3. PubMed ID: 17124252
[No Abstract] [Full Text] [Related]
36. B cells and autoimmune liver diseases.
Moritoki Y; Lian ZX; Ohsugi Y; Ueno Y; Gershwin ME
Autoimmun Rev; 2006 Aug; 5(7):449-57. PubMed ID: 16920571
[TBL] [Abstract][Full Text] [Related]
37. Ocrelizumab: a step forward in the evolution of B-cell therapy.
Kausar F; Mustafa K; Sweis G; Sawaqed R; Alawneh K; Salloum R; Badaracco M; Niewold TB; Sweiss NJ
Expert Opin Biol Ther; 2009 Jul; 9(7):889-95. PubMed ID: 19463076
[TBL] [Abstract][Full Text] [Related]
38. Acquired immune cytopenias post-cardiac transplantation respond to rituximab.
Tubman VN; Smoot L; Heeney MM
Pediatr Blood Cancer; 2007 Mar; 48(3):339-44. PubMed ID: 16435382
[TBL] [Abstract][Full Text] [Related]
39. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse.
Komura K; Fujimoto M; Yanaba K; Matsushita T; Matsushita Y; Horikawa M; Ogawa F; Shimizu K; Hasegawa M; Takehara K; Sato S
Ann Rheum Dis; 2008 Jun; 67(6):867-72. PubMed ID: 17823201
[TBL] [Abstract][Full Text] [Related]
40. B cell-targeted therapy in autoimmune disease: rationale, mechanisms, and clinical application.
Mease PJ
J Rheumatol; 2008 Jul; 35(7):1245-55. PubMed ID: 18609733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
